Skip to main content
Veterinary Medicines

CALIERMUTIN (MACROMUTIN) 162 mg/ml SOLUTION FOR INJECTION FOR PIGS

Authorised
  • Tiamulin

Product identification

Medicine name:
CALIERMUTIN (MACROMUTIN) 162 mg/ml SOLUTION FOR INJECTION FOR PIGS
MACROMUTIN 162 mg/ml SOLUCION INYECTABLE PARA PORCINO
Active substance:
  • Tiamulin
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Tiamulin
    162.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XQ01
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • Clear glass vials, quality type II (European Pharmacopoeia), of 100 ml, provided with grey brubber stoppers of bromobutyl, formulation PH 4001/45, and metallic aluminium coloured (silver) capsules with blue FLIP-OFF ring.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Calier S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2124 ESP
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/102/01/DC
Concerned member states:
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 12/11/2021
Download
Spanish (PDF)
Published on: 16/02/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 16/02/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."